https://idwiki.org/index.php?action=history&feed=atom&title=Adalimumab 2026-04-28T18:14:47Z Revision history for this page on the wiki MediaWiki 1.43.8 https://idwiki.org/index.php?title=Adalimumab&diff=9017&oldid=prev 2022-03-17T00:43:19Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 00:43, 17 March 2022</td> </tr><tr> <td colspan="2" class="diff-lineno">Line 2:</td> <td colspan="2" class="diff-lineno">Line 2:</td> </tr> <tr> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Indications include [[JIA]], [[RA]], [[Crohn disease]], [[ankylosing spondylitis]], chronic plaque [[psoriasis]], and [[psoriatic arthritis]]</div></td> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Indications include [[JIA]], [[RA]], [[Crohn disease]], [[ankylosing spondylitis]], chronic plaque [[psoriasis]], and [[psoriatic arthritis]]</div></td> </tr> <tr> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Infectious complications include bacterial infections (including severe [[pneumonia]]), [[TB]], [[candidiasis]], [[CMV]], [[toxoplasmosis]], and [[nocardiosis]]</div></td> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Infectious complications include bacterial infections (including severe [[pneumonia]]), [[TB]], [[candidiasis]], [[CMV]], [[toxoplasmosis]], and [[nocardiosis]]</div></td> </tr> <tr> <td colspan="2" class="diff-empty diff-side-deleted"></td> <td class="diff-marker" data-marker="+"></td> <td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>[[Category:TNF-α inhibitors]]</div></td> </tr> <tr> <td class="diff-marker" data-marker="−"></td> <td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><br /></td> <td colspan="2" class="diff-empty diff-side-added"></td> </tr> <tr> <td class="diff-marker" data-marker="−"></td> <td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>[[Category:<del style="font-weight: bold; text-decoration: none;">Medications</del>]]</div></td> <td class="diff-marker" data-marker="+"></td> <td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>[[Category:<ins style="font-weight: bold; text-decoration: none;">Monoclonal antibodies</ins>]]</div></td> </tr> </table>

Aidan https://idwiki.org/index.php?title=Adalimumab&diff=9016&oldid=prev 2022-03-17T00:42:47Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 00:42, 17 March 2022</td> </tr><tr> <td colspan="2" class="diff-lineno">Line 1:</td> <td colspan="2" class="diff-lineno">Line 1:</td> </tr> <tr> <td class="diff-marker" data-marker="−"></td> <td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>* Human IgG1 monoclonal antibody against TNF-α</div></td> <td class="diff-marker" data-marker="+"></td> <td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* Human IgG1 monoclonal antibody against <ins style="font-weight: bold; text-decoration: none;">[[Tumour necrosis factor-α inhibitors|</ins>TNF-α<ins style="font-weight: bold; text-decoration: none;">]]</ins></div></td> </tr> <tr> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Indications include [[JIA]], [[RA]], [[Crohn disease]], [[ankylosing spondylitis]], chronic plaque [[psoriasis]], and [[psoriatic arthritis]]</div></td> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Indications include [[JIA]], [[RA]], [[Crohn disease]], [[ankylosing spondylitis]], chronic plaque [[psoriasis]], and [[psoriatic arthritis]]</div></td> </tr> <tr> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Infectious complications include bacterial infections (including severe [[pneumonia]]), [[TB]], [[candidiasis]], [[CMV]], [[toxoplasmosis]], and [[nocardiosis]]</div></td> <td class="diff-marker"></td> <td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>* Infectious complications include bacterial infections (including severe [[pneumonia]]), [[TB]], [[candidiasis]], [[CMV]], [[toxoplasmosis]], and [[nocardiosis]]</div></td> </tr> </table>

Aidan https://idwiki.org/index.php?title=Adalimumab&diff=9015&oldid=prev 2022-03-17T00:42:28Z

<p>Created page with &quot;* Human IgG1 monoclonal antibody against TNF-α * Indications include <a href="/index.php?title=JIA&amp;action=edit&amp;redlink=1" class="new" title="JIA (page does not exist)">JIA</a>, <a href="/RA" class="mw-redirect" title="RA">RA</a>, <a href="/Crohn_disease" title="Crohn disease">Crohn disease</a>, <a href="/Ankylosing_spondylitis" title="Ankylosing spondylitis">ankylosing spondylitis</a>, chronic plaque <a href="/index.php?title=Psoriasis&amp;action=edit&amp;redlink=1" class="new" title="Psoriasis (page does not exist)">psoriasis</a>, and psori...&quot;</p> <p><b>New page</b></p><div>* Human IgG1 monoclonal antibody against TNF-α<br /> * Indications include [[JIA]], [[RA]], [[Crohn disease]], [[ankylosing spondylitis]], chronic plaque [[psoriasis]], and [[psoriatic arthritis]]<br /> * Infectious complications include bacterial infections (including severe [[pneumonia]]), [[TB]], [[candidiasis]], [[CMV]], [[toxoplasmosis]], and [[nocardiosis]]<br /> <br /> [[Category:Medications]]</div>

Aidan